Evidence map›Paper›PMID 37007216›Full record

ReviewTherapeutic advances in gastroenterology2023

Gastric peroral endoscopic pyloromyotomy (G-POEM) in patients with refractory gastroparesis: a review.

Grace Ann McCurdy, Tonia Gooden, Francesca Weis, Maryam Mubashir, Shazia Rashid, Syed Musa Raza, James Morris, Qiang Cai

Open access · goldAbstract readReview
In one paragraph

Review in Therapeutic advances in gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Enteric nervous system as a therapeutic target in gastrointestinal disorders.World journal of gastrointestinal pharmacology and therapeutics · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Grace Ann McCurdyDivision of Gastroenterology and Hepatology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Tonia GoodenDivision of Gastroenterology and Hepatology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Francesca WeisDivision of Gastroenterology and Hepatology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Maryam MubashirDivision of Gastroenterology and Hepatology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Shazia RashidDivision of Gastroenterology and Hepatology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Syed Musa RazaDivision of Gastroenterology and Hepatology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
James MorrisDivision of Gastroenterology and Hepatology, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
Qiang CaiDivision of Gastroenterology and Hepatology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Suite 6-230, Shreveport, LA 71103-4228, USA.ORCID https://orcid.org/0000-0002-9931-5410
Louisiana State University Health Sciences Center Shreveport · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric peroral endoscopic pyloromyotomy (G-POEM or POP) is an endoscopic therapeutic modality for treatment of refractory gastroparesis. Since the first case reported in 2013, there are more than 200 papers published on G-POEM. In this narrative review, we summarize the short-term and long-term outcomes and review other important studies. The technical success rate is 100% and the short-term (within 1 year) success rate is about 50-80%. The procedure time is between 50 and 70 min while the average length of hospital stay was 2-3 days. The adverse event rate was around 10%. Few patients need further intervention. Three studies showed that at the 4-year follow-up, the response to G-POEM was durable, but there was a yearly recurrence rate of 13% or more. Redo G-POEM is feasible and can be of benefit for some patients. Most of the studies showed that long duration of illness is associated with poor outcomes. However, reliable predictors for successful outcomes are still unknown. Current literature indicates G-POEM is superior to gastric electric stimulator and surgical pyloroplasty. Endoflip has been used at G-POEM to predict the outcome, but the result is very preliminary. A recent sham study confirms the short-term efficacy of G-POEM. G-POEM is safe and about 50% of patients can be discharged to home on the same day. G-POEM allows for direct biopsy of the gastric muscle, which is the location of the pacemaker cells, the interstitial cells of Cajal; therefore, G-POEM may provide a new path for further research on the pathogenesis of gastroparesis.

Indexed as

gastroparesisG-POEMmyotomyPOP

Identifiers

PMID37007216
PMCPMC10052481
OpenAlexW4360984926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.